NET silencing by let-7i in postural tachycardia syndrome

Journal of Clinical Investigation

Volumn 2, Issue 6, 2017, Pages

  Khan, Abdul Waheed ^a,b   Ziemann, Mark ^a   Corcoran, Susan J ^a   Harikrishnan, K N ^a,b   Okabe, Jun ^a   Rafehi, Haloom ^a   Maxwell, Scott S ^a   Esler, Murray D ^a   El Osta, Assam ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; MECP2 PROTEIN, HUMAN; METHYL CPG BINDING PROTEIN 2; NORADRENALIN TRANSPORTER; PROTEIN BINDING; SLC6A2 PROTEIN, HUMAN; VORINOSTAT;

DRUG EFFECT; FEMALE; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HELA CELL LINE; HUMAN; MALE; METABOLISM; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PROMOTER REGION;

EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; HELA CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; VORINOSTAT;

EID: 85041684549     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/jci.insight.90183     Document Type: Article

References (45)

1. Shannon JR, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000;342(8):541-549.
2. Beane M, Marrocco RT. Norepinephrine and acetylcholine mediation of the components of reflexive attention: implications for attention deficit disorders. Prog Neurobiol. 2004;74(3):167-181.
3. Pliszka SR. The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1385-1390.
4. Schlaich MP, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension. 2004;43(2):169-175.
5. Goldstein DS, Brush JE, Eisenhofer G, Stull R, Esler M. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation. 1988;78(1):41-48.
6. Bayles R, et al. Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arterioscler Thromb Vasc Biol. 2012;32(8):1910-1916.
7. Harikrishnan KN, et al. Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons. J Neurosci. 2010;30(4):1494-1501.
8. Harikrishnan KN, et al. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet. 2005;37(3):254-264.
9. Chahrour M, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;320(5880):1224-1229.
10. Goldstein DS, et al. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation. 2002;106(18):2358-2365.
11. Bovia F, et al. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood. 2003;101(5):1727-1733.
12. Young JI, et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA. 2005;102(49):17551-17558.
13. Dandrea M, Donadelli M, Costanzo C, Scarpa A, Palmieri M. MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic Acids Res. 2009;37(20):6681-6690.
14. Jones PL, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998;19(2):187-191.
15. Waibel M, et al. Manipulation of B-cell responses with histone deacetylase inhibitors. Nat Commun. 2015;6:6838.
16. Roger T, et al. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood. 2011;117(4):1205-1217.
17. Li D, Marchenko ND, Moll UM. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis. Cell Death Differ. 2011;18(12):1904-1913.
18. Harms MP, van Lieshout JJ. Cerebrovascular and cardiovascular responses associated with orthostatic intolerance and tachycardia. Clin Auton Res. 2001;11(1):35-38.
19. Mitchell EA, Gentet LJ, Dempster J, Belelli D. GABAA and glycine receptor-mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids. J Physiol (Lond). 2007;583(Pt 3):1021-1040.
20. Cifuentes-Rojas C, Hernandez AJ, Sarma K, Lee JT. Regulatory interactions between RNA and polycomb repressive complex 2. Mol Cell. 2014;55(2):171-185.
21. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J. 1998;17(17):4905-4908.
22. Bayles R, Baker E, Eikelis N, El-Osta A, Lambert G. Histone modifications regulate the norepinephrine transporter gene. Cell Cycle. 2010;9(22):4600-4601.
23. Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997;88(4):471-481.
24. Yasui DH, et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA. 2007;104(49):19416-19421.
25. Galvão TC, Thomas JO. Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain. Nucleic Acids Res. 2005;33(20):6603-6609.
26. Cukier HN, Perez AM, Collins AL, Zhou Z, Zoghbi HY, Botas J. Genetic modifiers of MeCP2 function in Drosophila. PLoS Genet. 2008;4(9):e1000179.
27. Zhu W, et al. MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction. PLoS ONE. 2011;6(2):e14736.
28. Jeffery L, Nakielny S. Components of the DNA methylation system of chromatin control are RNA-binding proteins. J Biol Chem. 2004;279(47):49479-49487.
29. Maxwell SS, Pelka GJ, Tam PP, El-Osta A. Chromatin context and ncRNA highlight targets of MeCP2 in brain. RNA Biol. 2013;10(11):1741-1757.
30. Udali S, Guarini P, Moruzzi S, Choi SW, Friso S. Cardiovascular epigenetics: from DNA methylation to microRNAs. Mol Aspects Med. 2013;34(4):883-901.
31. Puthanveetil P, Chen S, Feng B, Gautam A, Chakrabarti S. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J Cell Mol Med. 2015;19(6):1418-1425.
32. Shan K, et al. Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell Death Dis. 2016;7(6):e2248.
33. Long SW, Ooi JY, Yau PM, Jones PL. A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci Rep. 2011;31(5):333-343.
34. Rafehi H, et al. Vascular histone deacetylation by pharmacological HDAC inhibition. Genome Res. 2014;24(8):1271-1284.
35. Kong Y, et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation. 2006;113(22):2579-2588.
36. Zhao TC, Cheng G, Zhang LX, Tseng YT, Padbury JF. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res. 2007;76(3):473-481.
37. Colussi C, et al. The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice. Cardiovasc Res. 2010;87(1):73-82.
38. Xie M, et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation. 2014;129(10):1139-1151.
39. Keating ST, Plutzky J, El-Osta A. Epigenetic changes in diabetes and cardiovascular risk. Circ Res. 2016;118(11):1706-1722.
40. Rafehi H, El-Osta A. HDAC inhibition in vascular endothelial cells regulates the expression of ncRNAs. Non-Coding RNA. 2016;2(2):4.
41. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57-74.
42. Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15-21.
43. Yates A, et al. Ensembl 2016. Nucleic Acids Res. 2016;44(D1):D710-D716.
44. Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923-930.
45. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139-140.